Cargando…
Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control
BACKGROUND AND PURPOSE: To minimize cognitive decline without increasing brain tumor recurrence (BTR) by reduced-dose whole-brain radiotherapy (RD-WBRT) (25 Gy, 10 fractions) + stereotactic radiosurgery (SRS) in patients with ≤ 4 brain metastases. MATERIALS AND METHODS: Eligible patients with ≤ 4 br...
Autores principales: | Nakano, Toshimichi, Aoyama, Hidefumi, Onodera, Shunsuke, Igaki, Hiroshi, Matsumoto, Yasuo, Kanemoto, Ayae, Shimamoto, Shigetoshi, Matsuo, Masayuki, Tanaka, Hidekazu, Oya, Natsuo, Matsuyama, Tomohiko, Ohta, Atsushi, Maruyama, Katsuya, Tanaka, Takahiro, Kitamura, Nobutaka, Akazawa, Kohei, Maebayashi, Katsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529504/ https://www.ncbi.nlm.nih.gov/pubmed/36199814 http://dx.doi.org/10.1016/j.ctro.2022.09.005 |
Ejemplares similares
-
RT-04 Stereotactic irradiation for 2 - 3 cm brain metastases: A multicenter retrospective cohort study
por: Hirata, Takero, et al.
Publicado: (2020) -
Factors Affecting the Baseline and Post-Treatment Scores on the Hopkins Verbal Learning Test-Revised Japanese Version before and after Whole-Brain Radiation Therapy
por: Saito, Hirotake, et al.
Publicado: (2016) -
RADI-01. PROGNOSTIC FACTORS OF SHORT SURVIVAL FOR BRAIN METASTASES TREATED WITH SRS WITHOUT WBRT.
por: Harat, Maciej, et al.
Publicado: (2019) -
The neurocognitive function change criteria after whole-brain radiation therapy for brain metastasis, in reference to health-related quality of life changes: a prospective observation study
por: Nakano, Toshimichi, et al.
Publicado: (2020) -
Efficacy and safety of WBRT+EGFR‐TKI versus WBRT only in the treatment of NSCLC patients with brain metastasis: An updated meta‐analysis
por: Zhou, Kai, et al.
Publicado: (2021)